Page 13 - Trial Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Disproportionate number of cases within the gay community, she said that we should not stigmatize, of course, the community. we should not stigmatize this disease. we are all at risk here, but the virus is rare. so, again, not to panic. >> okay. thank you. it's the news so many parents of young children have been waiting for for the past couple years now. pfizer says the latest trial shows three child size doses of its vaccine are not only safe, but showed a strong immune response in children ages six months to five years. the company hopes to finish submitting the trial data to the fda this...

Proceeds will be used to advance clinical program of GNSC-001, company's lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D.,...

Started talking about additional vaccine boosters, 10 weeks after your boosted that immunity goes down to 35%, the efficacy goes down to 35%, 45% depending on the vaccine you've got. they reduced mortality by 51%, there's solid trial data supporting it, no data against it. i never heard doctor fauci or doctor wilensky say the word fluvoxamine. many universities included as recommended therapeutics on their covid website and merck and pfizer pills which we hear little about the they are ready to go and they are at pharmacies now. lisa: the government is failing us miserably, thank you so much f...

Pivotal vaccine trial was funded by the company and design, run, analyzed by pfizer employees and pfizer has indicated it will begin to entertaining request for trial data until may of 2025. nothing is going back to normal until the world is vaccinated now. joined me now, kentucky senator rand paul. a friend of mine who was a researcher himself sent that to me. two issues here, the world has to get vaccinated until we go back to normal and why is pfizer keeping its data secret? >> here's the deal, the world is being inoculated by the virus whether they like it or not to. people are getting thi...

Getting kids that baseline protection asap or waiting for more trial data on three doses? >> yeah, this reminds me of goldilocks and her oatmeal, right? the temperature had to be just right. we want that dose not too much, not too little, to be just right. and to be able to tell the public exactly what they are getting when they vaccinate their young children. and i think protection against hospitalization continues to be the big issue. and i think we'll need to give the fda and the companies enough time to get it just right. we don't want to rush into this. in the meantime, we have so many ch...